1. Home
  2. RVPH vs CSAI Comparison

RVPH vs CSAI Comparison

Compare RVPH & CSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • CSAI
  • Stock Information
  • Founded
  • RVPH 2006
  • CSAI N/A
  • Country
  • RVPH United States
  • CSAI
  • Employees
  • RVPH N/A
  • CSAI 18
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • CSAI
  • Sector
  • RVPH Health Care
  • CSAI
  • Exchange
  • RVPH Nasdaq
  • CSAI NYSE
  • Market Cap
  • RVPH 36.7M
  • CSAI 40.8M
  • IPO Year
  • RVPH N/A
  • CSAI N/A
  • Fundamental
  • Price
  • RVPH $0.70
  • CSAI $1.84
  • Analyst Decision
  • RVPH Strong Buy
  • CSAI
  • Analyst Count
  • RVPH 5
  • CSAI 0
  • Target Price
  • RVPH $9.00
  • CSAI N/A
  • AVG Volume (30 Days)
  • RVPH 662.3K
  • CSAI N/A
  • Earning Date
  • RVPH 08-13-2025
  • CSAI N/A
  • Dividend Yield
  • RVPH N/A
  • CSAI N/A
  • EPS Growth
  • RVPH N/A
  • CSAI N/A
  • EPS
  • RVPH N/A
  • CSAI N/A
  • Revenue
  • RVPH N/A
  • CSAI N/A
  • Revenue This Year
  • RVPH N/A
  • CSAI N/A
  • Revenue Next Year
  • RVPH N/A
  • CSAI N/A
  • P/E Ratio
  • RVPH N/A
  • CSAI N/A
  • Revenue Growth
  • RVPH N/A
  • CSAI N/A
  • 52 Week Low
  • RVPH $0.49
  • CSAI N/A
  • 52 Week High
  • RVPH $4.28
  • CSAI N/A
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 39.46
  • CSAI N/A
  • Support Level
  • RVPH $0.67
  • CSAI N/A
  • Resistance Level
  • RVPH $0.90
  • CSAI N/A
  • Average True Range (ATR)
  • RVPH 0.06
  • CSAI 0.00
  • MACD
  • RVPH -0.02
  • CSAI 0.00
  • Stochastic Oscillator
  • RVPH 11.36
  • CSAI 0.00

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About CSAI CLOUDASTRUCTURE INC

Cloudastructure Inc is engaged in cloud-based artificial intelligence (AI) video surveillance and Remote Guarding service built on AI and machine learning platforms. Its products/ services include Cloud Video Surveillance, Remote Guarding, Remote Guards, Cloud Video Recorder (CVR), Cameras and Speakers, Mobile Surveillance Trailer, etc.

Share on Social Networks: